Open Access DOI:10.23937/2378-2951/1410174
Covid-19 and the Cardiologist!
Sharma Prachi, MD, DNB, Sethi Rishi , MD, DM, FACC, FESC, FRCP (Edin.), FCSAI, FAPSIC, MAMS, FCSI, FISC and V S Narain, MD, DM, FSCAI, FESC
Article Type: Commentary | First Published: April 29, 2020
While the world is badly hit by this SARS-CoV-2 pandemic, the cardiologists have a special role to play and risks too to bear. Patients with known cardiovascular diseases are at a risk of increased morbidity and mortality by this infection. Also, Covid-19 may present with varied cardiovascular manifestations. This puts the upfront managing cardiologist and his team at greater risk of catching infection. So, they need to find the best possible way to help such patients with minimum possible risk ...
Open Access DOI:10.23937/2378-2951/1410173
National Trends and Outcomes of Myocardial Infarction: Result from National Inpatient Sample 2000 to 2015
Abdulrahman S Museedi, MD, Mouhamed Nashawi, BS, Abdullah Ghali, BS, Aws Alameri, MD, Mustafa Al Qaysi, MD and Robert Nathanson, MD, FACP
Article Type: Observational study | First Published: April 20, 2020
The burden of cardiovascular disease within the United States is profound, with large volumes of economic and academic resources being utilized to treat patients with cardiovascular diseases. Myocardial infarctions (MI) represent one of the most acute forms of cardiovascular pathology, with a profound mortality rate if prompt treatment and medical attention is not sought out after. While elements of changes in clinical practice and the spurring of new guidelines are responsible for improved heal...
Open Access DOI:10.23937/2378-2951/1410172
Coronary-Pulmonary Arterial Fistula in a Heart Transplant Patient
Weiliang Huang, MBBS, MRCP
Article Type: Case Report | First Published: April 21, 2020
A 40-year-old Indian gentleman has a history of dilated cardiomyopathy secondary to viral myocarditis. He was treated with heart failure medications, received an automated implantable cardioverter-defibrillator in 2005, and left ventricular assist device (LVAD) in 2009. He subsequently underwent an orthotopic heart transplant in 2011 at the age of 34. The donor was a 38-year old male patient with a brain tumour, which was complicated by seizures that resulted in hypoxic-ischaemic encephalopathy....
Open Access DOI:10.23937/2378-2951/1410171
Use of Bromocriptine for the Treatment of Peripartum Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
Danielle Louis E Villanueva, MD, Lauren Kay Evangelista, MD, Ma Cristina Espanillo-Villanueva, MD and John C Anonuevo, MD
Article Type: Research Article | First Published: April 10, 2020
Peripartum cardiomyopathy is a rare, pregnancy associated cause of left ventricular heart failure in previously healthy women. It remains an important cause of cardiac-related maternal morbidity and mortality worldwide. Half of the patients will recover left ventricular function after 6 months. However, in the remainder of patients who do not recover cardiac function, they will require advanced heart failure therapies. Bromocriptine, a dopamine agonist which inhibits prolactin release, has demon...
Open Access DOI:10.23937/2378-2951/1410170
A Case Report of Aspergillus Endocarditis, its Complications and Associated Morbidities
Jian Jing Tan, Sheldon Shao Guang Lee, Siang Chew Chai and Jason Jia Hao See
Article Type: Case Report | First Published: April 03, 2020
Fungal endocarditis is a notorious disease with a high mortality rate and commonly presents with embolic phenomenon. We report a case of prosthetic valve-related Aspergillus endocarditis with aortic root pseudoaneurysm that presented with acute limb ischemia. In addition, we highlight the significant morbidity that is associated with this fungal infection. With a high clinical index of suspicion and a multidisciplinary team approach, a favourable outcome can be achieved....
Open Access DOI:10.23937/2378-2951/1410169
Non-Bacterial Thrombotic (Marantic) Endocarditis of the Aortic Valve: A Rare Cause of STEMI Revealing a Polycythemia
Judit Ozse , Rainer Knur and Nicolas Von Beckerath
Article Type: Case report | First Published: March 24, 2020
Acute myocardial infarction is a major cause of death and disability worldwide. In general 4% to 7% of all patients diagnosed with AMI do not have coronary artery disease (CAD) at coronary angiography or autopsy. Embolisation as a mechanism of myocardial infarction is well known. Large diversity of aetiologies makes the precise diagnosis challenging. Its sources can be thrombi from left sided heart cavities, paradoxal embolism, tumors (myxoma, fibroelastoma), endocarditis (infective or nonbacter...
